| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Gilead Sciences, Inc. is a 10% Owner at GILD. Recent filings cover 11 purchases and 0 sales. Those positions are worth an estimated $611.7M at current prices.
Our model assigns Gilead Sciences, Inc. a strong insider score of 71/100, based on 10 past trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +29.8%.
Gilead Sciences, Inc.'s largest disclosed position is in GILD as 10% Owner, worth about $611.7M. Net of sales, the recent Form 4 record there shows accumulation of 32,763,748 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2021 | GILD Gilead Sciences, Inc. | 10% Owner | Buy | 5,650,000 | $39.00 | $220,350,000.00 | +68.4% |